NCT02956421View on ClinicalTrials.gov

Efficacy and Safety of a PIKA Rabies Vaccine Containing the PIKA Adjuvant With an Accelerated Regimen

PHASE2CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Rabies
Interventions
BIOLOGICAL

RABIPUR®

Biological rabies vaccine

BIOLOGICAL

PIKA rabies vaccine

Biological rabies vaccine

Trial Locations (2)

169608

SingHealth Investigational Medicine Unit, Singapore

529889

Clinical Trials & Research Unit, Singapore

All Listed Sponsors
lead

Yisheng Biopharma (Singapore) Pte. Ltd.

INDUSTRY

NCT02956421 - Efficacy and Safety of a PIKA Rabies Vaccine Containing the PIKA Adjuvant With an Accelerated Regimen | Biotech Hunter | Biotech Hunter